人工流产不全不同治疗方案的临床疗效分析

目的比较人工流产不全不同治疗方案的临床疗效，为临床治疗提供依据。方法将孕7-9周行手术流产发生人工流产不全、符合入组标准的120例患者随机分为4组，每组各30例。观察组1应用人工周期调经治疗，观察组2应用生化汤治疗，观察组3应用米非司酮治疗，对照组行清宫术治疗。比较4组患者临床疗效。结果观察组1患者治愈率90％，观察组2患者治愈率86.7％，观察组3患者治愈率90％，对照组患者治愈率93.3％，4组患者临床治疗效果差异无统计学意义（P〉0.05）。但对经量及经期影响，4组比较差异有统计学意义（P〈0.05）。结论药物治疗与手术清官治疗在人工流产不全患者中均获得较好的效果，而药物治疗对患者月经影响较小，同时可以避免对子宫内膜的损伤，降低二次清宫术的并发症发生。

Objective To provide the evidence for clinical treatment by comparing the clinical curative effect of the different treatment for incomplete artificial abortion. Methods 120 patients were divided into 4 groups, who meet the standard （ incomplete artificial abortion happens in the surgical abortion during 7 to 9 weeks of pregnancy ） . Observation Group 1 was adopted artificial menstrual cycle regulating method treatment. Observation Group 2 was adopted Shenghua decoction treatment. Observation Group 3 was adopted mifeptistone treatment. Control Group 4 was adopted curettage treatment. Results The cure rate of Group 1 was 90%, which was 86.7% in Group 2, 90% in Group 3 and 93.3% in Group 4. The differences of the therapeutic effect were not statistically significant （ P〉0.05 ） , but for the effect of menstrual blood volume and menstruation, it was statistically significant （ P〈0.05 ） . Conclusion Both drug therapy and curettage have a good effect on patients who have incomplete artificial abortion. However, the former has a smaller effect on menstruation. What＇s more, it can avoid the harm to endometrium and reduce the incidence of secondary curettage.